In parallel with the UK government announcing its Industrial Strategy – long-term plans for how the UK can retain and recover its economic strengths in a post-Brexit world – US pharma giant Merck & Co. Inc. has revealed it will establish a "state of the art life sciences discovery research facility" in London, focused on early bioscience discovery and entrepreneurial innovation.
While this is good news for the UK life science sector, it raises questions as to why Merck (known as...








